Consequence of RNA oxidation
Consequence of RNA oxidation
批准号:
7077505
负责人:
CHIEN-LIANG GLENN LIN
金额:
$19.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-01 至 2008-05-31
中文摘要
描述(由申请人提供):细胞质RNA氧化是阿尔茨海默病(AD)患者脑中脆弱神经元的显著特征。然而,RNA氧化在AD发病机制中的作用仍不清楚。我们最近开发了一种新的程序来分离和表征氧化的RNA。我们发现在AD脑中高达50%的poly(A)+mRNA被氧化。氧化的mRNA种类的鉴定显示,一些mRNA更容易受到氧化损伤;因此,RNA氧化不是随机的,而是高度选择性的。重要的是,许多已鉴定的氧化mRNA种类与AD的发病机制有关。对氧化损伤的mRNA的后果的研究表明,氧化的mRNA不能正确翻译,导致蛋白质表达减少,从而丧失正常的蛋白质功能。值得注意的是,将氧化的mRNA显微注射到神经元细胞中会导致细胞死亡,这表明增加的RNA氧化可能导致细胞死亡。此外,一些证据表明,RNA氧化是细胞死亡前的早期事件,而不是死亡细胞的人为因素。综合这些研究,RNA氧化本身与神经元退化直接相关,而不是神经退行性变过程中无害的副现象。这是一个重要但研究不足的领域。需要进一步详细调查。我们推测,mRNA的氧化损伤可能导致蛋白质功能障碍,这可能有助于AD中的神经元死亡。在目的1中,我们建议进一步确定氧化的mRNA种类的cDNA微阵列,量化每个氧化的mRNA的氧化水平,并调查相应的蛋白质在AD中确定的氧化的mRNA种类。本研究将鉴定这些高度氧化的mRNA种类,并确定与这些高度氧化的mRNA种类相对应的蛋白质是否有缺陷。在目标2中,我们提出研究RNA氧化的生物学后果。这些研究将阐明RNA氧化是否在AD的发病机制中起作用。
英文摘要
DESCRIPTION (provided by applicant): Cytoplasmic RNA oxidation is a prominent feature of vulnerable neurons in the brains of Alzheimer's disease (AD) patients. However, the role of RNA oxidation in the pathogenesis of AD is still unknown. We have recently developed a novel procedure to isolate and characterize oxidized RNA. We found that up to 50% of poly(A)+ mRNAs are oxidized in AD brains. Identification of oxidized mRNA species revealed that some mRNAs are more susceptible to oxidative damage; thus, RNA oxidation is not random but highly selective. Importantly, many identified oxidized mRNA species have been implicated in the pathogenesis of AD. Investigation of the consequence of oxidatively damaged mRNAs revealed that oxidized mRNA could not be translated properly leading to reduced protein expression and consequently, loss of normal protein function. Significantly, microinjection of oxidized mRNAs into neuronal cells leads to cell death, suggesting that increased RNA oxidation could lead to cell death. Furthermore, several lines of evidence suggest that RNA oxidation is an early event preceding cell death, not an artifact of dying cells. Taken these studies together, RNA oxidation itself is directly associated with neuronal deterioration instead of harmless epiphenomenona during the process of neurodegeneration. This is an important, yet understudied area. Further detailed investigation is needed. We hypothesize that oxidative damage to mRNA could result in protein malfunction, which could contribute to neuronal death in AD. In Aim 1, we propose to further identify oxidized mRNA species by cDNA microarray, to quantify the oxidation level for each oxidized mRNAs, and to investigate the proteins corresponding to the identified oxidized mRNA species in AD. This study will identify those highly oxidized mRNA species and determine whether proteins corresponding to those highly oxidized mRNA species are defective. In Aim 2, we propose to investigate the biological consequence of RNA oxidation. These studies will elucidate whether RNA oxidation plays a role in the pathogenesis of AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
-
批准号:10474460
-
项目类别:
-
资助金额:$148.9万
-
财政年份:2020
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
Target identification of small molecule LDN/OSU-215111
-
批准号:9885609
-
项目类别:
-
资助金额:$45.68万
-
财政年份:2020
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
-
批准号:10045319
-
项目类别:
-
资助金额:$155.25万
-
财政年份:2020
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
-
批准号:10263179
-
项目类别:
-
资助金额:$149.29万
-
财政年份:2020
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
Development of small molecule activators of glutamate transporter EAAT2 for treatment of Alzheimer's disease
-
批准号:9752404
-
项目类别:
-
资助金额:$54.3万
-
财政年份:2017
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
Translational regulation of glutamate transporter EAAT2 & therapeutic application
-
批准号:8114524
-
项目类别:
-
资助金额:$9.58万
-
财政年份:2009
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
Translational regulation of glutamate transporter EAAT2 & therapeutic application
-
批准号:7736933
-
项目类别:
-
资助金额:$45.04万
-
财政年份:2009
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
Consequence of RNA oxidation
-
批准号:7244082
-
项目类别:
-
资助金额:$15.42万
-
财政年份:2006
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
MECHANISMS FOR GLUTAMATE TRANSPORTER ALTERATIONS IN ALZH
-
批准号:6538930
-
项目类别:
-
资助金额:$21.2万
-
财政年份:1999
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
ABERRANT TRANSCRIPTS IN AGE RELATED NEURAL DISORDERS
-
批准号:6224286
-
项目类别:
-
资助金额:$7.3万
-
财政年份:1999
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
MECHANISMS FOR GLUTAMATE TRANSPORTER ALTERATIONS IN ALZH
-
批准号:6639106
-
项目类别:
-
资助金额:$21.73万
-
财政年份:1999
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
MECHANISMS FOR GLUTAMATE TRANSPORTER ALTERATIONS IN AD
-
批准号:6186763
-
项目类别:
-
资助金额:$24.23万
-
财政年份:1999
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
MECHANISMS FOR GLUTAMATE TRANSPORTER ALTERATIONS IN ALZH
-
批准号:6392477
-
项目类别:
-
资助金额:$23.99万
-
财政年份:1999
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
MECHANISMS FOR GLUTAMATE TRANSPORTER ALTERATIONS IN ALZH
-
批准号:2835675
-
项目类别:
-
资助金额:$5.55万
-
财政年份:1999
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
MECHANISMS FOR GLUTAMATE TRANSPORTER ALTERATIONS IN ALZH
-
批准号:6312600
-
项目类别:
-
资助金额:$14.68万
-
财政年份:1999
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
MOLECULAR DEFECTS IN GLUTAMATE TRANSPORTERS AND ALS
-
批准号:2668935
-
项目类别:
-
资助金额:$3.02万
-
财政年份:1998
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
MOLECULAR DEFECTS IN GLUTAMATE TRANSPORTERS AND ALS
-
批准号:2036927
-
项目类别:
-
资助金额:$2.54万
-
财政年份:1997
-
负责人:CHIEN-LIANG GLENN LIN
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: